GSK-257049

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGSK-257049
Drug Alias NameCSP-HBsAg (GlaxoSmithKline)RTS-S/SBAS2FSV-1-malaria-vaccine (GlaxoSmithKline)Malaria vaccine 257049 (GlaxoSmithKline)Plasmodium falciparum CSP/HBsAg (GlaxoSmithKline) +[25] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMalawi
Original Approved Date2019/04/23
Country/TerritoryBelgiumUnited StatesMozambique +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesUniversity Of Oxford
Active IndicationsMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeJ07X
Related LinksN/A